Molecular Templates, Inc.

Form Type: 8-K

Filing Date: 2025-01-02

Corporate Action: Liquidation

Type: New

Accession Number: 000119312525000647

Comments: On December 31, 2024, Molecular Templates, Inc. announced a significant leadership change and the approval of a wind-down of the company's affairs effective the same day. Six members of the Board of Directors, including CEO Dr. Eric E. Poma, resigned, and Dr. Poma will not receive severance. Dr. Poma's outstanding stock options will still vest until March 31, 2025. Craig Jalbert was appointed as the sole director and CEO, effective January 1, 2025, tasked with overseeing the wind-down of the company. The company cautioned investors about the speculative nature of trading its securities and advised that no value is expected to be realized by holders of its securities. Dr. Poma also signed a consulting agreement for transitional services and will be compensated hourly.

Document Link: View Document